Jaya Goyal, EVP, Res. & Preclin. Development at PepGen Inc. (PEPG), sold 392 shares at $20.00 ($8K) on 2023-03-24, disclosed to the SEC on 2023-03-28.
Scheduled sale ($8k) by EVP, Res. & Preclin. Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.